Lumos Diagnostics Announces Executive Changes

• Lumos Diagnostics announced Bronwyn Le Grice, Lawrence Mehren, and Catherine Robson will join Executive Chair Sam Lanyon and Executive Director Rob Sambursky.

• Bronwyn Le Grice brings more than eighteen years of executive experience in the health technology sector including venture capital, corporate development, and industry advocacy. 

• Lawrence Mehren provides diagnostic operational proficiency and public market experience. 

• Catherine Robson expands Lumos’ financial capabilities and corporate governance experience.

Lumos Diagnostics is a privately held biotechnology company based in Sarasota, Florida, and specializes in rapid, cost-effective, and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions.